HIGHLIGHTS
- who: January and colleagues from the Durham University, United Kingdom have published the research: Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study, in the Journal: (JOURNAL) of 19/08/2021
- what: This study investigates the incidence of bradycardia in SARS-Cov-2 patients who received Remdesivir and examines the effect of demographic characteristics, underlying risk factors, and the infection severity on developing sinus bradycardia as the most prevalent cardiac complication of Remdesivir. In the present study, the mean QTc interval duration shortened significantly after the fifth dose of Remdesivir compared . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.